HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-APR-10 3AGL TITLE COMPLEX OF PKA WITH THE BISUBSTRATE PROTEIN KINASE INHIBITOR ARC-1039 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT ALPHA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.11.11; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKACA, PRKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-285B(+) KEYWDS PKA, PROTEIN KINASE A, BISUBSTRATE INHIBITOR, ARC-1039, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.PFLUG,J.RAGOZINA,A.URI,D.BOSSEMEYER,R.A.ENGH REVDAT 4 30-OCT-24 3AGL 1 REMARK REVDAT 3 30-AUG-23 3AGL 1 COMPND REMARK HETNAM LINK REVDAT 2 13-JUL-11 3AGL 1 VERSN REVDAT 1 01-SEP-10 3AGL 0 JRNL AUTH A.PFLUG,J.ROGOZINA,D.LAVOGINA,E.ENKVIST,A.URI,R.A.ENGH, JRNL AUTH 2 D.BOSSEMEYER JRNL TITL DIVERSITY OF BISUBSTRATE BINDING MODES OF ADENOSINE JRNL TITL 2 ANALOGUE-OLIGOARGININE CONJUGATES IN PROTEIN KINASE A AND JRNL TITL 3 IMPLICATIONS FOR PROTEIN SUBSTRATE INTERACTIONS. JRNL REF J.MOL.BIOL. V. 403 66 2010 JRNL REFN ISSN 0022-2836 JRNL PMID 20732331 JRNL DOI 10.1016/J.JMB.2010.08.028 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0072 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.32 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 46179 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.237 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2459 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3351 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2220 REMARK 3 BIN FREE R VALUE SET COUNT : 185 REMARK 3 BIN FREE R VALUE : 0.2740 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5607 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 126 REMARK 3 SOLVENT ATOMS : 235 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.03000 REMARK 3 B22 (A**2) : -0.15000 REMARK 3 B33 (A**2) : 0.17000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.219 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.182 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.115 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.216 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.942 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.915 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5883 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7939 ; 1.258 ; 1.977 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 676 ; 5.361 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 286 ;36.061 ;24.126 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1040 ;14.529 ;15.043 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;19.737 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 826 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4456 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3390 ; 0.697 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5478 ; 1.323 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2493 ; 2.020 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2461 ; 3.315 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -10 A 9999 REMARK 3 ORIGIN FOR THE GROUP (A): -11.0430 0.1720 7.8720 REMARK 3 T TENSOR REMARK 3 T11: 0.0221 T22: 0.0727 REMARK 3 T33: 0.0281 T12: -0.0036 REMARK 3 T13: 0.0111 T23: 0.0062 REMARK 3 L TENSOR REMARK 3 L11: 0.7220 L22: 2.2964 REMARK 3 L33: 1.1376 L12: 0.0636 REMARK 3 L13: 0.1115 L23: -0.9219 REMARK 3 S TENSOR REMARK 3 S11: -0.0228 S12: 0.0648 S13: 0.0415 REMARK 3 S21: -0.0506 S22: -0.0318 S23: -0.1704 REMARK 3 S31: -0.0971 S32: 0.0843 S33: 0.0547 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A -10 B 9999 REMARK 3 ORIGIN FOR THE GROUP (A): -11.2590 50.0330 -25.2330 REMARK 3 T TENSOR REMARK 3 T11: 0.0209 T22: 0.0524 REMARK 3 T33: 0.0313 T12: -0.0018 REMARK 3 T13: 0.0030 T23: 0.0150 REMARK 3 L TENSOR REMARK 3 L11: 1.1787 L22: 2.4223 REMARK 3 L33: 0.7760 L12: -0.0045 REMARK 3 L13: 0.2126 L23: -0.4926 REMARK 3 S TENSOR REMARK 3 S11: -0.0114 S12: 0.0987 S13: 0.1863 REMARK 3 S21: -0.0641 S22: -0.0147 S23: -0.0565 REMARK 3 S31: -0.0987 S32: 0.0097 S33: 0.0262 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3AGL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-APR-10. REMARK 100 THE DEPOSITION ID IS D_1000029227. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-FEB-10 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 6.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.23985 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 48701 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 52.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.09600 REMARK 200 R SYM (I) : 0.09600 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.41300 REMARK 200 R SYM FOR SHELL (I) : 0.41300 REMARK 200 FOR SHELL : 4.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1CDK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 80 MM MES-BISTRIS, 75 MM LICL, 1.5 MM REMARK 280 OCTANOYL-N-METHYLGLUCAMIDE; MIXED 2:1 WITH AND EQUILIBRATED REMARK 280 AGAINST 40%(V/V) MPD, PH 6.9, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.59000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 53.23500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 53.23500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.59000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.58500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 GLY A 1 REMARK 465 ASN A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 LYS A 7 REMARK 465 LYS A 8 REMARK 465 GLY A 9 REMARK 465 MET B 0 REMARK 465 GLY B 1 REMARK 465 ASN B 2 REMARK 465 ALA B 3 REMARK 465 ALA B 4 REMARK 465 ALA B 5 REMARK 465 ALA B 6 REMARK 465 LYS B 7 REMARK 465 LYS B 8 REMARK 465 GLY B 9 REMARK 465 SEP B 10 REMARK 465 GLU B 11 REMARK 465 GLN B 12 REMARK 465 GLU B 13 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 336 O1P SEP A 338 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD1 ASP A 328 NH1 ARG B 194 4455 1.63 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 37 97.23 88.92 REMARK 500 ALA A 38 162.47 148.92 REMARK 500 ASP A 166 37.28 -147.08 REMARK 500 ASP A 184 83.52 64.25 REMARK 500 LEU A 273 42.04 -85.08 REMARK 500 LYS A 319 47.48 -103.03 REMARK 500 ASP B 112 -158.79 -135.70 REMARK 500 ASP B 166 36.91 -143.21 REMARK 500 ASP B 184 88.92 64.04 REMARK 500 ASN B 216 -162.57 -126.01 REMARK 500 LEU B 273 41.15 -90.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 630 REMARK 630 MOLECULE TYPE: NON-POLYMER INHIBITOR REMARK 630 MOLECULE NAME: (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-AMINO-9H-PURIN- REMARK 630 9-YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]-20,23-BIS(3- REMARK 630 CARBAMIMIDAMIDO PROPYL)-10-METHYL-1,8,11,18,21-PENTAOXO-2,9,12,19, REMARK 630 22-PENTAAZATETRACOSAN-24-AMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 A03 A 351 REMARK 630 A03 B 351 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 44A ACA DAL ACA DAR DAR NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A03 A 351 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE A03 B 351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3BWJ RELATED DB: PDB REMARK 900 RELATED ID: 3AG9 RELATED DB: PDB REMARK 900 RELATED ID: 3AGM RELATED DB: PDB DBREF 3AGL A 0 350 UNP P17612 KAPCA_HUMAN 1 351 DBREF 3AGL B 0 350 UNP P17612 KAPCA_HUMAN 1 351 SEQRES 1 A 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN SEQRES 2 A 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 A 351 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 A 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 A 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 A 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 A 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 A 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 A 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 A 351 TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SEQRES 11 A 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 A 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 A 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 A 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 A 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 A 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 A 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 A 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 A 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 A 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 A 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 A 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 A 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 A 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 A 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 A 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 A 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE SEQRES 1 B 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SEP GLU GLN SEQRES 2 B 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 B 351 PHE LEU LYS LYS TRP GLU SER PRO ALA GLN ASN THR ALA SEQRES 4 B 351 HIS LEU ASP GLN PHE GLU ARG ILE LYS THR LEU GLY THR SEQRES 5 B 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 B 351 THR GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 B 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 B 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 B 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 B 351 TYR MET VAL MET GLU TYR VAL PRO GLY GLY GLU MET PHE SEQRES 11 B 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 B 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 B 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 B 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 B 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 B 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 B 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 B 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 B 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 B 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 B 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 B 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 B 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 B 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 B 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 B 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 B 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE SER GLU PHE MODRES 3AGL SEP A 10 SER PHOSPHOSERINE MODRES 3AGL TPO A 197 THR PHOSPHOTHREONINE MODRES 3AGL SEP A 338 SER PHOSPHOSERINE MODRES 3AGL TPO B 197 THR PHOSPHOTHREONINE MODRES 3AGL SEP B 338 SER PHOSPHOSERINE HET SEP A 10 10 HET TPO A 197 11 HET SEP A 338 10 HET TPO B 197 11 HET SEP B 338 10 HET A03 A 351 63 HET A03 B 351 63 HETNAM SEP PHOSPHOSERINE HETNAM TPO PHOSPHOTHREONINE HETNAM A03 (10R,20R,23R)-1-[(2S,3S,4R,5R)-5-(6-AMINO-9H-PURIN-9- HETNAM 2 A03 YL)-3,4-DIHYDROXYTETRAHYDROFURAN-2-YL]-20,23-BIS(3- HETNAM 3 A03 CARBAMIMIDAMIDO PROPYL)-10-METHYL-1,8,11,18,21- HETNAM 4 A03 PENTAOXO-2,9,12,19,22-PENTAAZATETRACOSAN-24-AMIDE HETSYN SEP PHOSPHONOSERINE HETSYN TPO PHOSPHONOTHREONINE HETSYN A03 ARC-1039 FORMUL 1 SEP 3(C3 H8 N O6 P) FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 3 A03 2(C37 H63 N17 O9) FORMUL 5 HOH *235(H2 O) HELIX 1 1 SEP A 10 SER A 32 1 23 HELIX 2 2 HIS A 39 ASP A 41 5 3 HELIX 3 3 LYS A 76 LEU A 82 1 7 HELIX 4 4 GLN A 84 VAL A 98 1 15 HELIX 5 5 GLU A 127 GLY A 136 1 10 HELIX 6 6 SER A 139 LEU A 160 1 22 HELIX 7 7 LYS A 168 GLU A 170 5 3 HELIX 8 8 THR A 201 LEU A 205 5 5 HELIX 9 9 ALA A 206 LEU A 211 1 6 HELIX 10 10 LYS A 217 GLY A 234 1 18 HELIX 11 11 GLN A 242 SER A 252 1 11 HELIX 12 12 SER A 262 LEU A 273 1 12 HELIX 13 13 ASP A 276 ARG A 280 5 5 HELIX 14 14 VAL A 288 ASN A 293 1 6 HELIX 15 15 HIS A 294 ALA A 298 5 5 HELIX 16 16 ASP A 301 GLN A 307 1 7 HELIX 17 17 SER B 14 SER B 32 1 19 HELIX 18 18 HIS B 39 ASP B 41 5 3 HELIX 19 19 LYS B 76 LEU B 82 1 7 HELIX 20 20 GLN B 84 VAL B 98 1 15 HELIX 21 21 GLU B 127 GLY B 136 1 10 HELIX 22 22 SER B 139 LEU B 160 1 22 HELIX 23 23 LYS B 168 GLU B 170 5 3 HELIX 24 24 THR B 201 LEU B 205 5 5 HELIX 25 25 ALA B 206 LEU B 211 1 6 HELIX 26 26 LYS B 217 GLY B 234 1 18 HELIX 27 27 GLN B 242 GLY B 253 1 12 HELIX 28 28 SER B 262 LEU B 273 1 12 HELIX 29 29 ASP B 276 ARG B 280 5 5 HELIX 30 30 VAL B 288 ASN B 293 1 6 HELIX 31 31 HIS B 294 ALA B 298 5 5 HELIX 32 32 ASP B 301 GLN B 307 1 7 SHEET 1 A 5 PHE A 43 THR A 51 0 SHEET 2 A 5 GLY A 55 HIS A 62 -1 O VAL A 57 N LEU A 49 SHEET 3 A 5 HIS A 68 ASP A 75 -1 O MET A 71 N MET A 58 SHEET 4 A 5 ASN A 115 GLU A 121 -1 O MET A 120 N ALA A 70 SHEET 5 A 5 LEU A 106 LYS A 111 -1 N PHE A 110 O TYR A 117 SHEET 1 B 2 LEU A 162 ILE A 163 0 SHEET 2 B 2 LYS A 189 ARG A 190 -1 O LYS A 189 N ILE A 163 SHEET 1 C 2 LEU A 172 ILE A 174 0 SHEET 2 C 2 ILE A 180 VAL A 182 -1 O GLN A 181 N LEU A 173 SHEET 1 D 5 PHE B 43 THR B 51 0 SHEET 2 D 5 GLY B 55 HIS B 62 -1 O LYS B 61 N GLU B 44 SHEET 3 D 5 HIS B 68 ASP B 75 -1 O MET B 71 N MET B 58 SHEET 4 D 5 ASN B 115 GLU B 121 -1 O MET B 120 N ALA B 70 SHEET 5 D 5 LEU B 106 LYS B 111 -1 N GLU B 107 O VAL B 119 SHEET 1 E 2 LEU B 162 ILE B 163 0 SHEET 2 E 2 LYS B 189 ARG B 190 -1 O LYS B 189 N ILE B 163 SHEET 1 F 2 LEU B 172 ILE B 174 0 SHEET 2 F 2 ILE B 180 VAL B 182 -1 O GLN B 181 N LEU B 173 LINK C SEP A 10 N GLU A 11 1555 1555 1.33 LINK C TRP A 196 N TPO A 197 1555 1555 1.34 LINK C TPO A 197 N LEU A 198 1555 1555 1.33 LINK C VAL A 337 N SEP A 338 1555 1555 1.33 LINK C SEP A 338 N ILE A 339 1555 1555 1.33 LINK C TRP B 196 N TPO B 197 1555 1555 1.34 LINK C TPO B 197 N LEU B 198 1555 1555 1.33 LINK C VAL B 337 N SEP B 338 1555 1555 1.33 LINK C SEP B 338 N ILE B 339 1555 1555 1.33 CISPEP 1 ASN A 36 THR A 37 0 8.76 SITE 1 AC1 28 GLY A 52 SER A 53 PHE A 54 GLY A 55 SITE 2 AC1 28 VAL A 57 ALA A 70 VAL A 104 MET A 120 SITE 3 AC1 28 GLU A 121 TYR A 122 VAL A 123 GLU A 127 SITE 4 AC1 28 PHE A 129 ARG A 133 PRO A 169 GLU A 170 SITE 5 AC1 28 LEU A 173 THR A 183 GLU A 203 GLU A 230 SITE 6 AC1 28 PHE A 327 TYR A 330 HOH A 362 HOH A 370 SITE 7 AC1 28 HOH A 411 HOH A 447 HOH A 466 LYS B 192 SITE 1 AC2 27 LYS A 192 LEU B 49 THR B 51 GLY B 52 SITE 2 AC2 27 SER B 53 PHE B 54 GLY B 55 VAL B 57 SITE 3 AC2 27 ALA B 70 VAL B 104 GLU B 121 TYR B 122 SITE 4 AC2 27 VAL B 123 GLU B 127 PHE B 129 ARG B 133 SITE 5 AC2 27 PRO B 169 GLU B 170 LEU B 173 THR B 183 SITE 6 AC2 27 GLU B 230 PHE B 327 HOH B 375 HOH B 390 SITE 7 AC2 27 HOH B 401 HOH B 446 HOH B 448 CRYST1 73.180 105.170 106.470 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013665 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009508 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009392 0.00000 HETATM 1 N SEP A 10 6.181 -23.207 -0.768 1.00 63.59 N HETATM 2 CA SEP A 10 5.805 -22.979 -2.194 1.00 64.67 C HETATM 3 CB SEP A 10 5.542 -24.309 -2.914 1.00 66.56 C HETATM 4 OG SEP A 10 4.719 -24.115 -4.060 1.00 68.94 O HETATM 5 C SEP A 10 4.590 -22.067 -2.294 1.00 62.04 C HETATM 6 O SEP A 10 4.620 -21.042 -2.978 1.00 61.63 O HETATM 7 P SEP A 10 5.390 -24.671 -5.427 1.00 75.51 P HETATM 8 O1P SEP A 10 6.189 -26.051 -5.155 1.00 77.04 O HETATM 9 O2P SEP A 10 6.405 -23.571 -6.028 1.00 75.98 O HETATM 10 O3P SEP A 10 4.225 -24.928 -6.516 1.00 75.44 O